Ebola Vaccines Protect Monkeys

Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.

By | April 9, 2015

FLICKR, CDC GLOBALWhile a handful of Ebola vaccines are being trialed in humans, researchers are continuing to bring refined options up through the preclinical pipeline. A study published this week (April 8) in Nature provides evidence of the safety and efficacy of two novel vaccine candidates in macaque monkeys. Human safety trials could begin as early as this summer, senior author Thomas Geisbert of the University of Texas Medical Branch in Galveston told The New York Times.

The new vaccine candidates, under development by Profectus BioSciences, are improvements on a Merck vaccine currently being tested in Liberia; they used a more attenuated version of the vesicular stomatitis virus vector. While the vaccine that’s currently in trials can cause fever and joint and muscle pain, these new vaccines appeared to cause no side effects in eight vaccinated monkeys. Importantly, all eight animals survived a challenge with a virus from the current Ebola outbreak 28 days after immunization, while two control monkeys—which did not receive a vaccine—both died within a week, suggesting the more attenuated versions of the vector did not diminish the vaccines’ protection.

“[W]e are trying to find the balance between efficacy and safety,” Geisbert told Time.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  2. Two Dozen House Republicans Do an About-Face on Tuition Tax
  3. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  4. The Biggest DNA Origami Structures Yet
    Daily News The Biggest DNA Origami Structures Yet

    Three new strategies for using DNA to generate large, self-assembling shapes create everything from a nanoscale teddy bear to a nanoscale Mona Lisa.

FreeShip